{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:32:00Z","timestamp":1784619120485,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder associated with progressive impairment of spinal motor neurons. Continuous research endeavor is underway to fully understand the molecular mechanisms associating with this disorder. Although several studies have implied the involvement of inositol pyrophosphate IP<jats:sub>7<\/jats:sub> in ALS, there is no direct experimental evidence proving this notion. In this study, we analyzed inositol pyrophosphate IP<jats:sub>7<\/jats:sub> and its precursor IP<jats:sub>6<\/jats:sub> in the mouse and human ALS biological samples to directly assess whether IP<jats:sub>7<\/jats:sub> level and\/or its metabolism are altered in ALS disease state.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used a liquid chromatography-mass spectrometry (LC-MS) protocol originally-designed for mammalian IP<jats:sub>6<\/jats:sub> and IP<jats:sub>7<\/jats:sub> analysis. We measured the abundance of these molecules in the central nervous system (CNS) of ALS mouse model <jats:italic>SOD1<\/jats:italic>(G93A) transgenic (TG) mice as well as postmortem spinal cord of ALS patients. Cerebrospinal fluid (CSF) and peripheral blood mononuclear cells (PBMCs) from ALS patients were also analyzed to assess if IP<jats:sub>7<\/jats:sub> status in these biofluids is associated with ALS disease state.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:italic>SOD1<\/jats:italic>(G93A) TG mice showed significant increase of IP<jats:sub>7<\/jats:sub> level in the spinal cord compared with control mice at the late stage of disease progression, while its level in cerebrum and cerebellum remains constant. We also observed significantly elevated IP<jats:sub>7<\/jats:sub> level and its product-to-precursor ratio (IP<jats:sub>7<\/jats:sub>\/IP<jats:sub>6<\/jats:sub>) in the postmortem spinal cord of ALS patients, suggesting enhanced enzymatic activity of IP<jats:sub>7<\/jats:sub>-synthesizing kinases in the human ALS spinal cord. In contrast, human CSF did not contain detectable level of IP<jats:sub>6<\/jats:sub> and IP<jats:sub>7<\/jats:sub>, and neither the IP<jats:sub>7<\/jats:sub> level nor the IP<jats:sub>7<\/jats:sub>\/IP<jats:sub>6<\/jats:sub> ratio in human PBMCs differentiated ALS patients from age-matched healthy individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>By directly analyzing IP<jats:sub>7<\/jats:sub> in the CNS of ALS mice and humans, the findings of this study provide direct evidence that IP<jats:sub>7<\/jats:sub> level and\/or the enzymatic activity of IP<jats:sub>7<\/jats:sub>-generating kinases IP6Ks are elevated in ALS spinal cord. On the other hand, this study also showed that IP<jats:sub>7<\/jats:sub> is not suitable for biofluid-based ALS diagnosis. Further investigation is required to elucidate a role of IP<jats:sub>7<\/jats:sub> in ALS pathology and utilize IP<jats:sub>7<\/jats:sub> metabolism on the diagnostic application of ALS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1334004","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T04:43:30Z","timestamp":1704948210000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Elevation of inositol pyrophosphate IP7 in the mammalian spinal cord of amyotrophic lateral sclerosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Masatoshi","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ban","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Mizuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taira","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuka","family":"Netsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Kakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10654-018-0392-x","article-title":"Age-specific ALS incidence: a dose-response meta-analysis","volume":"33","author":"Marin","year":"2018","journal-title":"Eur J Epidemiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.15585\/mmwr.mm6746a1","article-title":"Prevalence of amyotrophic lateral sclerosis \u2013 United States, 2015","volume":"67","author":"Mehta","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/ije\/dyw061","article-title":"Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis","volume":"46","author":"Marin","year":"2017","journal-title":"Int J Epidemiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masroni","year":"2020","journal-title":"Eur J Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(08)70293-X","article-title":"Biomarkers in amyotrophic lateral sclerosis","volume":"8","author":"Turner","year":"2009","journal-title":"Lancet Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","article-title":"Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS","volume":"95","author":"Benatar","year":"2020","journal-title":"Neurology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e85533","DOI":"10.1371\/journal.pone.0085533","article-title":"Analysis of Dictyostelium discoideum inositol pyrophosphate metabolism by gel electrophoresis","volume":"9","author":"Pisani","year":"2014","journal-title":"PLoS ONE."},{"key":"B12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1042\/bj20020733","article-title":"Disruption and overexpression of the Schizosaccharomyces pombe aps1 gene, and effects on growth rate, morphology and intracellular diadenosine 5\u2032,5\u2033'-P1,P5-pentaphosphate and diphosphoinositol polyphosphate concentrations","volume":"369","author":"Ingram","year":"2003","journal-title":"Biochem J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1016\/S0021-9258(18)53551-1","article-title":"Turnover of inositol polyphosphate pyrophosphates in pancreatoma cells","volume":"268","author":"Menniti","year":"1993","journal-title":"J Biol Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1074\/jbc.M409416200","article-title":"Inositol hexakisphosphate kinase-2, a physiologic mediator of cell death","volume":"280","author":"Nagata","year":"2005","journal-title":"J Biol Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/BJ20090241","article-title":"Inositol pyrophosphates modulate hydrogen peroxide signalling","volume":"423","author":"Onnebo","year":"2009","journal-title":"Biochem J."},{"key":"B16","first-page":"13","article-title":"Inositol hexakisphosphate kinase 2 is a presymptomatic biomarker for amyotrophic lateral sclerosis","volume":"42","author":"Moriya","year":"2017","journal-title":"Tokai J Exp Clin Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1007\/s12035-015-9470-1","article-title":"inositol hexakisphosphate kinase 2 promotes cell death in cells with cytoplasmic TDP-43 aggregation","volume":"53","author":"Nagata","year":"2016","journal-title":"Mol Neurobiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.chroma.2018.08.061","article-title":"Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the quantitative analysis of mammalian-derived inositol poly\/pyrophosphates","volume":"1573","author":"Ito","year":"2018","journal-title":"J Chromatogr A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"102928","DOI":"10.1016\/j.jbc.2023.102928","article-title":"Inositol pyrophosphate profiling reveals regulatory roles of IP6K2-dependent enhanced IP7 metabolism in the enteric nervous system","volume":"299","author":"Ito","year":"2023","journal-title":"J Biol Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/146608200300079536","article-title":"El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"150014","DOI":"10.1098\/rsob.150014","article-title":"A novel method for the purification of inositol phosphates from biological samples reveals that no phytate is present in human plasma or urine","volume":"5","author":"Wilson","year":"2015","journal-title":"Open Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbadis.2006.03.006","article-title":"Transgenic mouse models of amyotrophic lateral sclerosis","volume":"1762","author":"Julien","year":"2006","journal-title":"Biochim Biophys Acta."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/acn3.50943","article-title":"Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS Ann Clin Transl Neurol","volume":"6","author":"Kasai","year":"2019"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1038\/s41467-021-24934-8","article-title":"The enzymatic activity of inositol hexakisphosphate kinase controls circulating phosphate in mammals","volume":"12","author":"Moritoh","year":"2021","journal-title":"Nat Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1039\/D2SC05147H","article-title":"Capillary electrophoresis mass spectrometry identifies new isomers of inositol pyrophosphates in mammalian tissues","volume":"14","author":"Qiu","year":"2022","journal-title":"Chem Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"9553","DOI":"10.3390\/ijms22179553","article-title":"Transcriptomic meta-analysis shows lipid metabolism dysregulation as an early pathological mechanism in the spinal cord of SOD1 mice","volume":"22","author":"Fern\u00e1ndez-Beltr\u00e1n","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"806000","DOI":"10.3389\/fnagi.2022.806000","article-title":"Functional screening of Parkinson's disease susceptibility genes to identify novel modulators of \u03b1-synuclein neurotoxicity in Caenorhabditis elegans","volume":"14","author":"Vozdek","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"991641","DOI":"10.3389\/fmolb.2022.991641","article-title":"Aging RNA granule dynamics in neurodegeneration","volume":"9","author":"Rhine","year":"2022","journal-title":"Front Mol Biosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"19245","DOI":"10.1073\/pnas.1922284117","article-title":"InsP7 is a small-molecule regulator of NUDT3-mediated mRNA decapping and processing-body dynamics","volume":"117","author":"Sahu","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"jcs259117","DOI":"10.1242\/jcs.259117","article-title":"IP6K1 upregulates the formation of processing bodies by influencing protein-protein interactions on the mRNA cap","volume":"134","author":"Shah","year":"2021","journal-title":"J Cell Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0092-8674(03)00640-8","article-title":"Inositol pyrophosphates mediate chemotaxis in dictyostelium via pleckstrin homology domain-PtdIns(3,4,5)P3 interactions","volume":"114","author":"Luo","year":"2003","journal-title":"Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.cell.2010.11.032","article-title":"Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain","volume":"143","author":"Chakraborty","year":"2010","journal-title":"Cell."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6035","DOI":"10.1038\/s41467-020-19928-x","article-title":"Analysis of inositol phosphate metabolism by capillary electrophoresis electrospray ionization mass spectrometry","volume":"11","author":"Qiu","year":"2020","journal-title":"Nat Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"26680","DOI":"10.1074\/jbc.M111.220749","article-title":"Inositol hexakisphosphate kinases induce cell death in Huntington disease","volume":"286","author":"Nagata","year":"2011","journal-title":"J Biol Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.bbadis.2016.06.014","article-title":"Contribution of polymorphic variation of inositol hexakisphosphate kinase 3 (IP6K3) gene promoter to the susceptibility to late onset Alzheimer's disease","volume":"1862","author":"Crocco","year":"2016","journal-title":"Biochim Biophys Acta."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1334004\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T04:43:35Z","timestamp":1704948215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1334004\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":35,"alternative-id":["10.3389\/fneur.2023.1334004"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1334004","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]},"article-number":"1334004"}}